Clinical Trials Logo

Clinical Trial Summary

the cyclosporine showed efficacy in many immune cytopenic diseases in the light of numerous case reports and retrospective data. This study compares cyclosporin versus rituximab in steroid-refractory anemia.


Clinical Trial Description

Auto-immune hemolytic anemia (AIHA) is a heterogeneous syndrome in adults. This disease is associated with significant morbidity-mortality. First-line treatment with prolonged corticosteroid is well identified but there is not enough data about cyclosporine treatment in case of resistance or dependence on steroids. the cyclosporine showed efficacy in many immune cytopenic diseases in the light of numerous case reports and retrospective data. This drug is cheap, licensed in immunologic diseases, and does not expose to major infections. So, we compare cyclosporin versus rituximab in steroid-refractory anemia. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05057468
Study type Interventional
Source Assiut University
Contact
Status Not yet recruiting
Phase Phase 3
Start date September 18, 2021
Completion date November 30, 2022